Physician profile
Sujatha Mohan
NPI 1891936860
$2,623.40
in general payments reported to CMS, 2019-2025
30 companies · $315 in 2025
The $315 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $251 · 2020: $241 · 2021: $540 · 2022: $628 · 2023: $418 · 2024: $231 · 2025: $315.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $964.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $964.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $628.54 | 2020-2023 | |
| Exeltis, USA INC. | $260.16 | 2020-2025 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $209.60 | 2019-2023 | |
| Mayne Pharma Commercial LLC | $178.06 | 2022-2024 | |
| Astellas Pharma US INC | $154.67 | 2023-2025 | Veozah, Myrbetriq |
| Biogen, INC. | $118.95 | 2025 | Zurzuvae |
| Hologic Sales and Service, LLC | $118.70 | 2019-2023 | Aptima |
| Coopersurgical, INC. | $90.07 | 2020-2025 | Paragard T 380a, Paragard T 380a |
| Pfizer INC. | $84.30 | 2022-2025 | |
| Avion Pharmaceuticals | $84.19 | 2019-2022 | |
| Ethicon US, LLC | $82.45 | 2021-2024 | Evarrest, Ethicon, Enseal |
| Organon LLC | $81.15 | 2021-2023 | Nexplanon |
| Mylan Pharmaceuticals INC. | $73.17 | 2020-2022 | |
| Lupin INC. | $54.58 | 2019-2021 | |
| Allergan, INC. | $53.24 | 2019-2020 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $41.34 | 2019 | |
| Scynexis, INC. | $34.41 | 2021-2022 | |
| Millicent US INC | $33.22 | 2019-2025 | Intrarosa, Femring |
| Merck Sharp & Dohme LLC | $28.23 | 2019 | |
| Boston Scientific Corporation | $24.44 | 2024 | |
| Medtronic, INC. | $23.85 | 2023 | Ligasure |
| Sumitomo Pharma America, INC. | $22.21 | 2024 | Myfembree |
| Exact Sciences Corporation | $21.79 | 2025 | Cologuard Collection Kit |
| Intuitive Surgical, INC. | $20.58 | 2019 | |
| Biom'Up France Sas | $19.75 | 2020 | |
| Mission Pharmacal Company | $16.80 | 2020 | |
| Smith+Nephew, INC. | $16.56 | 2021 | |
| Meditrina | $16.49 | 2022 | |
| Agile Therapeutics, INC. | $16.03 | 2023 | Twirla |
| Aspira Women'S Health INC | $15.87 | 2024 | Ova1 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sujatha Mohan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.